[1] |
中华医学会外科学分会胆道外科学组, 中国医师协会外科医师分会胆道外科专业委员会. 胆囊癌诊断和治疗指南(2019版)[J]. 中华外科杂志, 2020, 58(4):243-251.
|
[2] |
耿智敏,汤朝晖. 2018年NCCN指南更新版胆囊癌诊治进展述评[J]. 西部医学, 2018, 30(7):937-942, 947.
|
[3] |
Mahul BA, Stephen E, Frederick LG, et al. AJCC cancer staging manual[M]. 8th ed. New York: Springer, 2016.
|
[4] |
Lee W, Jeong CY, Jang JY, et al. Do hepatic-sided tumors require more extensive resection than peritoneal-sided tumors in patients with T2 gallbladder cancer? results of a retrospective multicenter study[J]. Surgery, 2017, 162(3):515-524.
|
[5] |
张东,耿智敏,陈晨,等. 胆囊癌的临床分型和预后关系初步分析:多中心回顾性临床研究[J]. 中华外科杂志, 2019, 57(4):258-264.
|
[6] |
Fong Y, Jarnagin W, Blumgart LH. Gallbladder cancer: comparison of patients presenting initially for definitive operation with those presenting after prior noncurative intervention[J]. Ann Surg, 2000, 232(4):557-569.
|
[7] |
Hueman MT, Vollmer CM Jr, Pawlik TM. Evolving treatment strategies for gallbladder cancer[J]. Ann Surg Oncol, 2009, 16(8): 2101-2115.
|
[8] |
Hundal R, Shaffer EA. Gallbladder cancer: epidemiology and outcome[J]. Clin Epidemiol, 2014(6):99-109.
|
[9] |
Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2):115-132.
|
[10] |
Deoliveira ML, Schulick RD, Nimura Y, et al. New staging system and a registry for perihilar cholangiocarcinoma[J]. Hepatology, 2011, 53(4):1363-1371.
|
[11] |
Wu Y, Li Q, Cai Z, et al. Survival prediction for gallbladder carcinoma after curative resection: comparison of nomogram and Bayesian network models[J]. Eur J Surg Oncol, 2020, 46(11):2106-2113.
|
[12] |
Kishi Y, Nara S, Esaki M, et al. Extent of lymph node dissection in patients with gallbladder cancer[J]. Br J Surg, 2018, 105(12):1658-1664.
|
[13] |
Lamarca A, Edeline J, McNamara MG, et al. Current standards and future perspectives in adjuvant treatment for biliary tract cancers[J]. Cancer Treat Rev, 2020(84):101936.
|
[14] |
Kato A, Shimizu H, Ohtsuka M, et al. Downsizing chemotherapy for initially unresectable locally advanced biliary tract cancer patients treated with gemcitabine plus cisplatin combination therapy followed by radical surgery[J]. Ann Surg Oncol, 2015, 22 Suppl 3:S1093-1099.
|
[15] |
Shindoh J, de Aretxabala X, Aloia TA, et al. Tumor location is a strong predictor of tumor progression and survival in T2 gallbladder cancer: an international multicenter study[J]. Ann Surg, 2015, 261(4): 733-739.
|
[16] |
陈孝平, 陈汉, 沈锋, 等. 肝胆外科学[M]. 北京: 人民卫生出版社, 2005:27-29.
|
[17] |
Lee H, Choi DW, Park JY, et al. Surgical strategy for T2 gallbladder cancer according to tumor location[J]. Ann Surg Oncol, 2015, 22(8): 2779-2786.
|
[18] |
Leigh N, Pletcher E, Solomon D, et al. The significance of anatomic tumor location in gallbladder cancer[J]. J Surg Oncol, 2021, 123(4): 932-938.
|
[19] |
Kondo S, Nimura Y, Kamiya J, et al. Mode of tumor spread and surgical strategy in gallbladder carcinoma[J]. Langenbecks Arch Surg, 2002, 387(5/6):222-228.
|
[20] |
王建承, 费健, 蒋渝, 等. 原发性胆囊癌的预后与病理和手术类型的关系[J]. 中华普通外科杂志, 2001, 16(2):85-87.
|
[21] |
俞文隆, 杨晓宇, 张永杰. 胆囊癌扩大根治性切除术的范围与术式选择[J]. 中国实用外科杂志, 2011, 31(3):209-212.
|
[22] |
Krell RW, Wei AC. Gallbladder cancer: surgical management[J]. Chin Clin Oncol, 2019, 8(4):36.
|
[23] |
Long Y, Wang L, Sun M. Structure extension of tree-augmented naive Bayes[J]. Entropy, 2019, 21(8):721.
|